Secondary hyperparathyroidism
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with end stage renal disease receiving hemodialysis Patients with moderate to severe secondary hyperparathyroidism Patients who provide informed consent for the study
Exclusion criteria
Exclusion criteria: Unstable medical condition Currently enrolled another investigational device or drug Pregnancy or breast feeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change from baseline in oxidative stress markers | — |
Countries
Japan
Contacts
Kobe University School of Medicine Division of Nephrology and Kidney Center